BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• 

  Podcast

  BioSpace at Meeting on the Mesa, WuXi Considers Selling U.S. Facilities, Big Pharma Layoffs, More

  Cell and gene therapy investment rebounds; WuXi Biologics and other companies named in BIOSECURE Act mull options; Bayer, J&J and Pfizer’s recent layoffs; updates from the weight loss space.

  October 9, 2024

   · 

  1 min read

   · 

  Heather McKenzie
• 

  Artificial intelligence

  Lilly, Insitro Ink Unique AI Deal, Eye Novel Treatments for Metabolic Diseases

  In a departure from most deals, startup insitro will in-license Lilly’s delivery technology for its investigational liver-targeted siRNA therapies. The pharma will be eligible for milestones and royalties down the line.

  October 9, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Deals

  5 Radiopharma Biotechs to Watch for Potential Buyouts

  Big Pharma can’t seem to get enough radiopharmaceutical biotechs. With Lilly, Sanofi and BMS chasing Novartis into the complex space, all eyes are on these specialty biotechs.

  October 9, 2024

   · 

  5 min read

   · 

  Annalee Armstrong
• Press Releases

  Bausch Health and Salix Survey Highlights Urgent Need for Improved Understanding of Liver Disease Across Healthcare Provider Disciplines as Prevalence of Cirrhosis Rises

  October 9, 2024

   · 

  5 min read
• Press Releases

  SIGA Announces Agreement to Supply TPOXX® in Morocco

  October 9, 2024

   · 

  5 min read
• Press Releases

  CorMedix Announces New Commercial Agreement with Mid-Sized Dialysis Operator

  October 9, 2024

   · 

  4 min read
• Press Releases

  Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

  October 9, 2024

   · 

  5 min read
• Press Releases

  Scholar Rock Announces Pricing of Upsized $300 Million Public Offering of Common Stock and Pre-Funded Warrants

  October 9, 2024

   · 

  5 min read
• Press Releases

  Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

  October 9, 2024

   · 

  5 min read
• Press Releases

  Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases

  October 9, 2024

   · 

  6 min read